Upcoming webinar: Speech as a biomarker in Ataxia: What can it tell us & how should we use it?


E2di2R_XMAA02Cl.jpgRedenlab CSO, Adam Vogel, will be presenting at the upcoming joint webinar with the European Reference Network for rare or low prevalence complex diseases, Neurological Diseases (ERN-RND), Neuromuscular Dieseases (ERN EURO-NMD), and European Academy of Neurology. The subject of the webinar is Speech as a biomarker in Ataxia: What can it tell us & how should we use it. Sign up here!

Related Post

  • Posted on 10 March, 2023
    Primary Progressive Aphasia is a type of young onset dementia that is characterised by language impairment. Measuring disease progression and...
    • Posted on 10 March, 2023
      Stereotypical depictions of speech in cannabis users often suggest slow, laboured output, yet objective evidence supporting this assumption is extremely...
      • Posted on 10 March, 2023
        Speech is a cardinal and important feature of ataxia. We have put together a comprehensive description of dysarthria in spinocerebellar...